Lista de obras - Barbara Uzonyi - Dominio Público Uruguay

Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.

artículo científico publicado en 2014

Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles

artículo científico publicado en 2009

Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi

artículo científico publicado en 2010

Complement receptor type 1 (CR1/CD35) expressed on activated human CD4+ T cells contributes to generation of regulatory T cells

artículo científico publicado en 2015

Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells

artículo científico publicado en 2006

FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.

artículo científico publicado en 2017

Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro.

artículo científico publicado en 2015

Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation

artículo científico publicado en 2015

Factor H-related proteins determine complement-activating surfaces

artículo científico

Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R.

artículo científico publicado en 2017

Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4.

artículo científico publicado en 2017

Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome

artículo científico publicado en 2015

Human vascular smooth muscle cells express functionally active endothelial cell protein C receptor

artículo científico publicado en 2006

Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.

artículo científico publicado en 2016

The Murine Factor H-Related Protein FHR-B Promotes Complement Activation

artículo científico publicado en 2017

The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease. ⬇️

artículo científico publicado en 2015

Lista de obras de Barbara Uzonyi

Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.

Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles

Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi

Complement receptor type 1 (CR1/CD35) expressed on activated human CD4+ T cells contributes to generation of regulatory T cells

Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells

FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.

Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro.

Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation

Factor H-related proteins determine complement-activating surfaces

Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R.

Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4.

Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome

Human vascular smooth muscle cells express functionally active endothelial cell protein C receptor

Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.

The Murine Factor H-Related Protein FHR-B Promotes Complement Activation

The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease. ⬇️